Source: FinanzNachrichten

Accord Healthcare: Accord Healthcare is granted marketing authorisation for IMULDOSA, ustekinumab biosimilar to Stelara

LONDON, Dec. 16, 2024 /PRNewswire/ -- Accord announces that the European Commission (EC has granted marketing authorisation for Imuldosa® (development code: DMB-3115), a biosimilar to Stelara®, in...

Read full article »
Accord Healthcare's Competitors | Accord Healthcare's News | Accord Healthcare's Financials
Stay up-to-date with the latest news on Accord Healthcare
Est. Annual Revenue
$100-500M
Est. Employees
500-1.0K
Peter Kelly's photo - Managing Director of Accord Healthcare

Managing Director

Peter Kelly

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Accord Healthcare